HCA Healthcare (HCA)
(Delayed Data from NYSE)
$403.52 USD
+3.63 (0.91%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $403.65 +0.13 (0.03%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth F Momentum B VGM
Cash flow Statements
Fiscal Year End for HCA Healthcare, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 6,091.00 | 6,834.00 | 7,721.00 | 4,387.00 | 4,145.00 |
Depreciation/Amortization & Depletion | 3,112.00 | 2,998.00 | 2,880.00 | 2,751.00 | 2,626.00 |
Net Change from Assets/Liabilities | -457.00 | -581.00 | -573.00 | 1,278.00 | 162.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 685.00 | -729.00 | -1,069.00 | 816.00 | 669.00 |
Net Cash From Operating Activities | 9,431.00 | 8,522.00 | 8,959.00 | 9,232.00 | 7,602.00 |
Property & Equipment | -4,744.00 | -4,395.00 | -3,577.00 | -2,835.00 | -4,158.00 |
Acquisition/ Disposition of Subsidiaries | -442.00 | 1,013.00 | 1,055.00 | -500.00 | -1,621.00 |
Investments | -112.00 | 14.00 | -117.00 | -20.00 | 25.00 |
Other Investing Activities | -19.00 | -21.00 | -4.00 | -38.00 | 34.00 |
Net Cash from Investing Activities | -5,317.00 | -3,389.00 | -2,643.00 | -3,393.00 | -5,720.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -3,811.00 | -7,000.00 | -8,215.00 | -441.00 | -1,031.00 |
Issuance (Repayment) of Debt | 1,295.00 | 3,287.00 | 3,255.00 | -3,217.00 | 567.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -661.00 | -653.00 | -624.00 | -153.00 | -550.00 |
Other Financing Activities | -917.00 | -1,290.00 | -1,071.00 | -866.00 | -757.00 |
Net Cash from Financing Activities | -4,094.00 | -5,656.00 | -6,655.00 | -4,677.00 | -1,771.00 |
Effect of Exchange Rate Changes | 7.00 | -20.00 | -3.00 | 10.00 | 8.00 |
Net Change In Cash & Equivalents | 27.00 | -543.00 | -342.00 | 1,172.00 | 119.00 |
Cash at Beginning of Period | 908.00 | 1,451.00 | 1,793.00 | 621.00 | 502.00 |
Cash at End of Period | 935.00 | 908.00 | 1,451.00 | 1,793.00 | 621.00 |
Diluted Net EPS | 18.97 | 19.15 | 21.16 | 10.93 | 10.07 |
Fiscal Year End for HCA Healthcare, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 3,489.00 | 1,802.00 | 6,091.00 | 4,230.00 | 2,955.00 |
Depreciation/Amortization & Depletion | 1,631.00 | 804.00 | 3,112.00 | 2,314.00 | 1,536.00 |
Net Change from Assets/Liabilities | -812.00 | -86.00 | -457.00 | -231.00 | -500.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 132.00 | -51.00 | 685.00 | 444.00 | 287.00 |
Net Cash From Operating Activities | 4,440.00 | 2,469.00 | 9,431.00 | 6,757.00 | 4,278.00 |
Property & Equipment | -2,399.00 | -1,118.00 | -4,744.00 | -3,585.00 | -2,438.00 |
Acquisition/ Disposition of Subsidiaries | 180.00 | 214.00 | -442.00 | -98.00 | 48.00 |
Investments | -14.00 | 2.00 | -112.00 | -30.00 | -16.00 |
Other Investing Activities | -2.00 | -1.00 | -19.00 | -7.00 | -2.00 |
Net Cash from Investing Activities | -2,235.00 | -903.00 | -5,317.00 | -3,720.00 | -2,408.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -2,547.00 | -1,180.00 | -3,811.00 | -2,901.00 | -1,761.00 |
Issuance (Repayment) of Debt | 1,184.00 | 537.00 | 1,295.00 | 1,109.00 | 770.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -356.00 | -185.00 | -661.00 | -501.00 | -339.00 |
Other Financing Activities | -590.00 | -388.00 | -917.00 | -762.00 | -593.00 |
Net Cash from Financing Activities | -2,309.00 | -1,216.00 | -4,094.00 | -3,055.00 | -1,923.00 |
Effect of Exchange Rate Changes | 0.00 | -1.00 | 7.00 | 1.00 | 7.00 |
Net Change In Cash & Equivalents | -104.00 | 349.00 | 27.00 | -17.00 | -46.00 |
Cash at Beginning of Period | 935.00 | 935.00 | 908.00 | 908.00 | 908.00 |
Cash at End of Period | 831.00 | 1,284.00 | 935.00 | 891.00 | 862.00 |
Diluted Net EPS | 5.53 | 5.93 | 5.92 | 3.91 | 4.29 |